Focusing on drug related harm minimisation CSAW Health manufactures a range of personal sharps containers in Australia - the CPAK range. In addition we also import several containers to provide customers with an extensive choice of high-quality products. The containers include both injection and blow-moulded products ranging from a single disposal device through to a 1.8L disposal container. CSAW Health also provides a comprehensive range of related products for the compilation of NSP kits. These high quality products can be sold separately or pre-packaged into a kit designed to suit your specific needs. Items sold separately include an extensive range of Terumo and BD sharps devices, personal lubricants, condoms, swabs, filters as well as our own range of personal sharps containers.
In addition, CSAW Health is an approved distributor for the Disposafit Brand. We can supply and install a range of robust community sharps bins ranging from the small 1.4Ltr for installation in public toilets through to a 240 ltrs community disposal bin. The Disposafit brand of community disposal bins are all manufactured to the highest standard by Vendafit Pty Ltd.
CSAW Health has strived to reduce barriers to purchasing our products and so where possible all products may be purchased by Government, NGO’s, NSPs, trade customers and the general public. The only products that are not available for sale to trade customers and the general public are sharps and water for injection due to current legislation.
If we don’t stock an item you require then please contact us and we will endeavour to procure it and make it available for sale.
"Epidemics of HIV among injecting drug users (IDUs) have been prevented, even where there is no decrease in drug use or injecting. Countries which have been most successful in this are countries which have adopted the public health approach known as ‘harm reduction’. Because it is the sharing of contaminated injecting equipment which is responsible for the transmission of HIV among IDUs, decreasing this sharing must be the prime target for prevention efforts. ‘Manual for reducing drug related harm in Asia’ Ed. Nick Crofts (Centre for Harm Reduction, Victoria, Australia)"
"In terms of the effectiveness of NSPs in preventing hepatitis C infection, it is estimated that between 1988 and 2001, 21,000 hepatitis C infections were prevented across Australia among people who inject. Consequently it is estimated that 16,000 cases of hepatitis C will have been prevented and 90 hepatitis C-related deaths avoided by 2010. "